| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.71B | 3.63B | 3.34B | 3.96B | 4.53B |
| Gross Profit | 867.44M | 835.78M | 648.67M | 643.86M | 754.30M |
| EBITDA | 174.46M | 502.83M | 440.01M | 330.96M | 377.55M |
| Net Income | 771.06M | 709.21M | 593.67M | 347.06M | 288.34M |
Balance Sheet | |||||
| Total Assets | 9.51B | 9.33B | 9.21B | 9.23B | 9.74B |
| Cash, Cash Equivalents and Short-Term Investments | 4.79B | 5.94B | 6.26B | 5.93B | 6.22B |
| Total Debt | 12.52M | 15.60M | 17.61M | 15.91M | 52.29M |
| Total Liabilities | 1.24B | 1.12B | 1.02B | 1.11B | 1.35B |
| Stockholders Equity | 7.94B | 7.87B | 7.84B | 7.80B | 8.06B |
Cash Flow | |||||
| Free Cash Flow | 740.62M | 51.19M | 515.37M | 159.19M | 248.38M |
| Operating Cash Flow | 760.12M | 67.81M | 523.12M | 169.66M | 262.80M |
| Investing Cash Flow | -2.79B | 3.10B | 941.73M | 118.07M | 441.51M |
| Financing Cash Flow | -811.26M | -661.18M | -535.14M | -479.65M | -458.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$89.80B | 7.76 | 48.55% | 9.80% | 11.50% | 17.54% | |
79 Outperform | HK$65.45B | 5.50 | 5.92% | 5.72% | 12.77% | -18.46% | |
78 Outperform | HK$9.44B | 11.77 | 9.59% | 8.83% | 2.17% | 8.72% | |
74 Outperform | HK$21.30B | 8.82 | 5.04% | 4.97% | 10.96% | -4.09% | |
71 Outperform | HK$91.07B | 7.02 | 11.33% | 12.81% | -9.21% | -41.30% | |
65 Neutral | HK$247.26B | 6.39 | 13.13% | 12.48% | -6.12% | -35.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |